South Korea
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.84 B
|
Dec. 31, 2023 | USD 745.69 | 1.15% |
|
South Korea |
|
2 |
USD 2.63 B
|
Dec. 31, 2023 | USD 5.23 | -2.06% |
|
South Korea |
|
3 |
USD 1.67 B
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
4 |
USD 1.58 B
|
Dec. 31, 2023 | USD 9.61 | -3.70% |
|
South Korea |
|
5 |
USD 1.43 B
|
Dec. 31, 2023 | USD 83.97 | -5.00% |
|
South Korea |
|
6 |
USD 1.39 B
|
Dec. 31, 2023 | USD 13.69 | -2.57% |
|
South Korea |
|
7 |
USD 1.28 B
|
Dec. 31, 2023 | USD 56.39 | -4.53% |
|
South Korea |
|
8 |
USD 1.25 B
|
Dec. 31, 2023 | USD 88.80 | -5.65% |
|
South Korea |
|
9 |
USD 1.16 B
|
Dec. 31, 2023 | USD 3.69 | -1.06% |
|
South Korea |
|
10 |
USD 1.15 B
|
Dec. 31, 2023 | USD 159.35 | -4.24% |
|
South Korea |
|
11 |
USD 1.06 B
|
Dec. 31, 2023 | USD 89.76 | -4.42% |
|
South Korea |
|
12 |
USD 958.39 M
|
Dec. 31, 2023 | USD 18.22 | -3.57% |
|
South Korea |
|
13 |
USD 869.38 M
|
Dec. 31, 2023 | USD 65.38 | -0.04% |
|
South Korea |
|
14 |
USD 675.67 M
|
Dec. 31, 2023 | USD 31.05 | -1.12% |
|
South Korea |
|
15 |
USD 660.19 M
|
Dec. 31, 2023 | USD 6.82 | -1.91% |
|
South Korea |
|
16 |
USD 582.44 M
|
Dec. 31, 2023 | USD 23.36 | -2.28% |
|
South Korea |
|
17 |
USD 574.87 M
|
Dec. 31, 2023 | USD 15.49 | -2.92% |
|
South Korea |
|
18 |
USD 561.40 M
|
Dec. 31, 2023 | USD 9.85 | -4.50% |
|
South Korea |
|
19 |
USD 509.94 M
|
Dec. 31, 2023 | USD 33.57 | -2.13% |
|
South Korea |
|
20 |
USD 503.56 M
|
Dec. 31, 2023 | USD 8.02 | 4.65% |
|
South Korea |
|
21 |
USD 404.70 M
|
Dec. 31, 2023 | USD 9.80 | -1.72% |
|
South Korea |
|
22 |
USD 401.47 M
|
Dec. 31, 2023 | USD 7.87 | -2.10% |
|
South Korea |
|
23 |
USD 298.59 M
|
Dec. 31, 2023 | USD 34.59 | -4.65% |
|
South Korea |
|
24 |
USD 295.64 M
|
Dec. 31, 2023 | USD 12.66 | -2.66% |
|
South Korea |
|
25 |
USD 283.78 M
|
Dec. 31, 2023 | USD 32.21 | -3.61% |
|
South Korea |
|
26 |
USD 282.14 M
|
Dec. 31, 2023 | USD 15.77 | -2.26% |
|
South Korea |
|
27 |
USD 277.33 M
|
Dec. 31, 2023 | USD 4.07 | -1.95% |
|
South Korea |
|
28 |
USD 272.56 M
|
Dec. 31, 2023 | USD 70.28 | -5.55% |
|
South Korea |
|
29 |
USD 224.35 M
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
30 |
USD 218.87 M
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
31 |
USD 202.17 M
|
Dec. 31, 2023 | USD 11.53 | -7.22% |
|
South Korea |
|
32 |
USD 198.94 M
|
Dec. 31, 2023 | USD 7.33 | -4.07% |
|
South Korea |
|
33 |
USD 180.41 M
|
Dec. 31, 2023 | USD 1.37 | -0.64% |
|
South Korea |
|
34 |
USD 176.94 M
|
Dec. 31, 2023 | USD 7.90 | -1.67% |
|
South Korea |
|
35 |
USD 169.82 M
|
Dec. 31, 2023 | USD 77.77 | -3.69% |
|
South Korea |
|
36 |
USD 153.78 M
|
Dec. 31, 2023 | USD 6.88 | -1.99% |
|
South Korea |
|
37 |
USD 150.79 M
|
Dec. 31, 2023 | USD 8.58 | -5.12% |
|
South Korea |
|
38 |
USD 130.83 M
|
Dec. 31, 2023 | USD 16.51 | 0.47% |
|
South Korea |
|
39 |
USD 130.23 M
|
Dec. 31, 2023 | USD 1.12 | -3.94% |
|
South Korea |
|
40 |
USD 128.09 M
|
Dec. 31, 2023 | USD 2.87 | -2.35% |
|
South Korea |
|
41 |
USD 123.15 M
|
Dec. 31, 2023 | USD 14.37 | -3.79% |
|
South Korea |
|
42 |
USD 119.67 M
|
Dec. 31, 2023 | USD 11.86 | -0.20% |
|
South Korea |
|
43 |
USD 116.02 M
|
Dec. 31, 2023 | USD 8.44 | -2.89% |
|
South Korea |
|
44 |
USD 105.38 M
|
Dec. 31, 2023 | USD 3.01 | -3.95% |
|
South Korea |
|
45 |
USD 103.97 M
|
Dec. 31, 2023 | USD 3.25 | -3.09% |
|
South Korea |
|
46 |
USD 103.08 M
|
Dec. 31, 2023 | USD 11.00 | -3.03% |
|
South Korea |
|
47 |
USD 96.71 M
|
Dec. 31, 2023 | USD 3.10 | -3.13% |
|
South Korea |
|
48 |
USD 86.36 M
|
Dec. 31, 2023 | USD 9.81 | -0.42% |
|
South Korea |
|
49 |
USD 75.26 M
|
Dec. 31, 2023 | USD 7.21 | -0.62% |
|
South Korea |
|
50 |
USD 74.13 M
|
Dec. 31, 2023 | USD 240.05 | -5.25% |
|
South Korea |
The Healthcare company in South Korea with the highest Revenue is Samsung Biologics Co.,Ltd. (KSE: 207940.KS) at USD 2.84 B.
The Healthcare company in South Korea with the lowest Revenue is Cellid, Co., Ltd. (KOSDAQ: 299660.KQ) at USD 0.00.
The top 10 Healthcare companies in South Korea by Revenue are Samsung Biologics Co.,Ltd., iMarketKorea Inc., Celltrion, Inc., Green Cross Holdings Corporation, Yuhan Corporation, Daewoong Co., Ltd., Chong Kun Dang Pharmaceutical Corp., Green Cross Corporation, Kwang Dong Pharmaceutical Co., Ltd. and Hanmi Pharm. Co., Ltd..
The bottom 10 Healthcare companies in South Korea by Revenue are Cellid, Co., Ltd., MedPacto, Inc., Gencurix Inc., Peptron, Inc., SillaJen, Inc., Helixmith Co., Ltd, Genexine, Inc., CrystalGenomics, Inc., Oscotec Inc. and Anterogen.Co.,Ltd..